Fisher-HochSP, CravenRB, ForthallDN.Safe intensive care management of a severe case of Lassa fever with simple barrier nursing techniques.Lancet1985; ii: 1227–9.
13.
HolmesGP, McCormickJB, TrockSC.Lassa fever in the United States.N Engl J Med1990; 323: 1120–3.
MaizteguiJI, FernandezNJ, de DamilanoAJ. Efficacy of immune plasma in treatment of Argentinian haemorrhagic fever and association between treatment and a late neurological syndrome.Lancet1979; ii: 1216–17.
16.
YanagiharaR.Hanta virus infection in the United States, epizootology and epidemiology.Rev Infect Dis1990; 12: 449–57.
17.
Anon.Ebola virus infection.BMJ1977; ii: 539–40.
18.
BowenETW, PlattGS, LloydG, BaskervilleA, HarrisWJ, VellaEE. Viral haemorrhagic fever in southern Sudan and northern Zaire.Lancet1977; ii: 571–3.
19.
JohnsonKM, WebbPA, LangeJV, MurphyFA. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.Lancet1977; ii: 569–71.
20.
DyerO.Ebola threat eases.BMJ1995; 310: 1353.
21.
BennetD, BrownD.Ebola virus.BMJ1995; 310: 1344–5.
22.
Update-management of patients with suspected viral haemorrhagic fever—United States.JAMA1995; 274: 374–5.
23.
LeDucJW, TkhomirovE.Global surveillance for recognition and response to emerging diseases.Ann NY Acad Sci1994; 740: 341–5.
24.
JohnJJ. Emerging and re-emerging threats to human health.Natl Med J Ind1996; 9: 1–2.